Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,092 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications.
Nilsson C, Linde F, Hulegårdh E, Garelius H, Lazarevic V, Antunovic P, Cammenga J, Deneberg S, Eriksson A, Jädersten M, Björkvall CK, Möllgård L, Wennström L, Ölander E, Höglund M, Juliusson G, Lehmann S. Nilsson C, et al. Haematologica. 2023 Apr 1;108(4):1015-1025. doi: 10.3324/haematol.2022.281233. Haematologica. 2023. PMID: 36005563 Free PMC article.
Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience.
Lazarevic V, Hörstedt AS, Johansson B, Antunovic P, Billström R, Derolf A, Hulegårdh E, Lehmann S, Möllgård L, Nilsson C, Peterson S, Stockelberg D, Uggla B, Wennström L, Wahlin A, Höglund M, Juliusson G. Lazarevic V, et al. Among authors: nilsson c. Blood Cancer J. 2014 Feb 28;4(2):e188. doi: 10.1038/bcj.2014.10. Blood Cancer J. 2014. PMID: 24583534 Free PMC article.
Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry.
Hulegårdh E, Nilsson C, Lazarevic V, Garelius H, Antunovic P, Rangert Derolf Å, Möllgård L, Uggla B, Wennström L, Wahlin A, Höglund M, Juliusson G, Stockelberg D, Lehmann S. Hulegårdh E, et al. Among authors: nilsson c. Am J Hematol. 2015 Mar;90(3):208-14. doi: 10.1002/ajh.23908. Epub 2015 Jan 16. Am J Hematol. 2015. PMID: 25421221 Free article.
High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia.
Karimi M, Nilsson C, Dimitriou M, Jansson M, Matsson H, Unneberg P, Lehmann S, Kere J, Hellström-Lindberg E. Karimi M, et al. Among authors: nilsson c. Haematologica. 2015 Jun;100(6):e223-5. doi: 10.3324/haematol.2014.118034. Epub 2015 Mar 13. Haematologica. 2015. PMID: 25769547 Free PMC article. No abstract available.
Expression levels of long non-coding RNAs are prognostic for AML outcome.
Mer AS, Lindberg J, Nilsson C, Klevebring D, Wang M, Grönberg H, Lehmann S, Rantalainen M. Mer AS, et al. Among authors: nilsson c. J Hematol Oncol. 2018 Apr 7;11(1):52. doi: 10.1186/s13045-018-0596-2. J Hematol Oncol. 2018. PMID: 29625580 Free PMC article.
Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting.
Nilsson C, Hulegårdh E, Garelius H, Möllgård L, Brune M, Wahlin A, Lenhoff S, Frödin U, Remberger M, Höglund M, Juliusson G, Stockelberg D, Lehmann S. Nilsson C, et al. Biol Blood Marrow Transplant. 2019 Sep;25(9):1770-1778. doi: 10.1016/j.bbmt.2019.05.038. Epub 2019 Jun 6. Biol Blood Marrow Transplant. 2019. PMID: 31176789 Free article.
1,092 results